Renal pathology resulting from PGHS-2 gene ablation in DBA/B6 mice

被引:6
作者
Laulederkind, SJF
Wall, BM
Ballou, LR
Raghow, R
机构
[1] Univ Tennessee, Dept Vet Affairs Med Ctr, Res Serv 151, Memphis, TN 38104 USA
[2] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA
[3] Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA
[4] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA
来源
PROSTAGLANDINS & OTHER LIPID MEDIATORS | 2002年 / 70卷 / 1-2期
关键词
prostaglandin H synthase-2; murine; kidney; hypoplasia;
D O I
10.1016/S0090-6980(02)00063-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Kidneys of prostaglandin H synthase-2 (PGHS-2) null mice fail to develop normally, leading to renal insufficiency. We have found that in a mixed DBA/B6 background, the lack of a functional PGHS-2 gene causes less severe renal pathology than was reported previously for PGHS-2 null mice in a B6 genetic background. The increase in blood urea nitrogen in the DBA/136 strain of PGHS-2 null mice was significantly lower than reported for B6 PGHS-2 null mice (200% versus 270%). Cystic changes in DBA/B6 PGHS-2 null mice were also less severe. The DBA/B6 PGHS-2 null adult mice did not die from renal failure, unlike their B6/PGHS-2 counterparts that showed excessive neonatal and adult deaths. Therefore, DBA/B6 PGHS-2 null may be highly suitable to study the functional consequences of the lack of PGHS-2 in the kidney due to their less severe pathology and greater survival. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:161 / 168
页数:8
相关论文
共 17 条
[1]   Insight into prostaglandin, leukotriene, and other eicosanoid functions using mice with targeted gene disruptions [J].
Austin, SC ;
Funk, CD .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1999, 58 (5-6) :231-252
[2]  
AVNER ED, 1985, IN VITRO CELL DEV B, V21, P297
[3]   Nociception in cyclooxygenase isozyme-deficient mice [J].
Ballou, LR ;
Botting, RM ;
Goorha, S ;
Zhang, JY ;
Vane, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (18) :10272-10276
[4]  
BALLOU LR, 2001, THERAPEUTIC ROLE COX, P128
[5]  
Bennett LM, 2000, MOL CARCINOGEN, V28, P174, DOI 10.1002/1098-2744(200007)28:3<174::AID-MC6>3.0.CO
[6]  
2-C
[7]   GENETIC IDENTIFICATION OF MOM-1, A MAJOR MODIFIER LOCUS AFFECTING MIN-INDUCED INTESTINAL NEOPLASIA IN THE MOUSE [J].
DIETRICH, WF ;
LANDER, ES ;
SMITH, JS ;
MOSER, AR ;
GOULD, KA ;
LUONGO, C ;
BORENSTEIN, N ;
DOVE, W .
CELL, 1993, 75 (04) :631-639
[8]   RENAL ABNORMALITIES AND AN ALTERED INFLAMMATORY RESPONSE IN MICE LACKING CYCLOOXYGENASE-II [J].
DINCHUK, JE ;
CAR, BD ;
FOCHT, RJ ;
JOHNSTON, JJ ;
JAFFEE, BD ;
COVINGTON, MB ;
CONTEL, NR ;
ENG, VM ;
COLLINS, RJ ;
CZERNIAK, PM ;
GORRY, SA ;
TRZASKOS, JM .
NATURE, 1995, 378 (6555) :406-409
[9]  
Kömhoff M, 2000, KIDNEY INT, V57, P414
[10]   PROSTAGLANDIN-SYNTHASE-1 GENE DISRUPTION IN MICE REDUCES ARACHIDONIC ACID-INDUCED INFLAMMATION AND INDOMETHACIN-INDUCED GASTRIC-ULCERATION [J].
LANGENBACH, R ;
MORHAM, SG ;
TIANO, HF ;
LOFTIN, CD ;
GHANAYEM, BI ;
CHULADA, PC ;
MAHLER, JF ;
LEE, CA ;
GOULDING, EH ;
KLUCKMAN, KD ;
KIM, HS ;
SMITHIES, O .
CELL, 1995, 83 (03) :483-492